Jianfeng Group 2017 Profit Distribution Implementation Announcement
Release time:
2020-07-07
Securities Code: 600668 Securities Short Name: Jianfeng Group Announcement No.: 2018-019
Bond Short Name: 13 Jianfeng 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd. 2017 Annual Equity Distribution Implementation Announcement
The board of directors and all directors of the company guarantee that the content of this announcement does not contain any false records, Misleading statements or major omissions, and bear individual and joint responsibility for the authenticity, accuracy and completeness of its contents. |
Important Tips:
l Distribution Ratio per Share
A Share Cash Dividend per Share 0.1 Yuan
l Relevant Date
Share Category |
Share Registration Date |
Last Trading Date |
Ex-rights (dividend) Date |
Cash Dividend Payment Date |
A Shares |
2018/7/5 |
- |
2018/7/6 |
2018/7/6 |
l Differential Dividend Transfer: no
1. the session and date of the shareholders' meeting that approved the distribution plan
This profit distribution plan was reviewed and approved by the company's 2017 annual shareholders' meeting on May 18, 2018.
2. Distribution Plan
1. Issuance Year: 2017 Year
2. Distribution Object:
As of the afternoon of the equity registration date, after the Shanghai Stock Exchange closes, in China Securities Depository and Clearing Co., Ltd. All shareholders of the company registered in the Shanghai branch (hereinafter referred to as "China Clearing Shanghai Branch").
3. Distribution Plan:
This profit distribution is based on 344,083,828 shares of the company's total share capital before the implementation of the plan. A cash dividend of 0.1 yuan (tax included) is distributed per share, and a total cash dividend of 34,408,382.80 yuan is distributed.
3. Relevant Date
Share Class |
Share Registration Date |
Last Trading Date |
ex-rights (dividend) Date |
Cash Dividend Payment Date |
A Share |
2018/7/5 |
- |
2018/7/6 |
2018/7/6 |
4. Distribution Implementation Measures
1. Implementation Measures
(1) Except Jinhua Tongji State-owned Assets investment Co., Ltd. is issued directly by the Company, the dividends of other unrestricted tradable shares are entrusted to China Clearing Shanghai Branch through its capital clearing system to be distributed to shareholders who have registered after the closing of the Shanghai Stock Exchange on the equity registration date and have handled designated transactions on the members of the Shanghai Stock Exchange. Investors who have handled designated transactions can receive cash dividends at their designated securities business department on the dividend payment date. Shareholders' dividends that have not handled designated transactions are temporarily kept by China Clearing Shanghai Branch and will be distributed after the designated transactions are handled.
2. Self-distributed object
The cash dividends of the company's shareholder Jinhua Tongji State-owned Assets Investment Co., Ltd. are directly distributed by the company.
3. Tax Deduction Note
(1) Cash dividends for natural person shareholders and securities investment funds holding unrestricted tradable shares of the Company, in accordance with the relevant provisions of the Notice on Issues Relating to Differentiated Individual Income Tax Policies on Dividends and Bonuses of Listed Companies (Caishui [2015] No. 101) and the Notice on Issues Relating to the Implementation of Differentiated Individual Income Tax Policies on Dividends and Bonuses of Listed Companies (Caishui [2012] No. 85), if the holding period (the holding period refers to the duration from the date when an individual acquires the company's shares in the public offering and transfer market to the day before the transfer and delivery of the shares) is less than one month (including one month), the full amount of dividend income shall be included in the taxable income, and the actual tax burden shall be 20%; if the holding period is more than one month to one year (including one year), its dividend income is included in the taxable income at 50%, and the actual tax burden is 10%; if the holding period exceeds 1 year, the dividend income is temporarily exempt from personal income tax. The company does not withhold personal income tax for the time being. When it transfers its shares, Zhongdeng Shanghai Branch will calculate the tax payable according to its shareholding period, and the securities company and other share custodian institutions will deduct and pay Zhongdeng Shanghai Branch from its capital account. Zhongdeng Shanghai Branch will pay the company within 5 working days of the following month, and the company will report and pay the tax to the competent tax authority within the statutory reporting period of the month in which the month.
(2) for the cash dividends of qualified foreign institutional investors (QFII) holding shares of the company, according to the relevant provisions of the notice on issues related to the withholding of enterprise income tax on dividends, dividends and interest paid by Chinese resident enterprises to QFII (Guoshuihan [2009] No. 47) (hereinafter referred to as the "notice"), the company shall withhold and pay enterprise income tax at a tax rate of 10%, after tax deduction, the actual cash dividend per share is 0.09 yuan. If the relevant shareholder considers that the dividend income received by him is subject to any tax treaty (arrangement) treatment, the shareholder may, in accordance with the provisions of the Notice, apply to the competent tax authorities on his own initiative after the dividend has been received.
(3) For investors (including enterprises and individuals) on the Hong Kong Stock Exchange who invest in the Company's A- shares ("Shanghai Stock Connect"), their cash dividends will be distributed by the Company through Zhongdeng Shanghai Branch in RMB according to the account of the nominal holder of the shares, tax deduction is implemented in accordance with the "Notice of the Ministry of Finance, the State Administration of Taxation, and the China Securities Regulatory Commission on the Relevant Tax Policies for the Pilot Interconnection Mechanism of Shanghai and Hong Kong Stock Market Transactions" (Caishui [2014] No. 81). The actual cash dividend per share is RMB 0.09.
(4) For company shareholders (including institutional investors) who belong to the meaning of resident enterprises under the "Enterprise Income Tax Law", their income tax is paid by themselves, and the actual cash dividend is RMB 0.1 per share.
5. Relevant Consultation Measures
Contact Department: Office of the Board of Directors of the Company
Contact Department: 0579-82324699
Tel: 0579-82324699
is hereby announced.
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
July 2, 2018
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31